复方补肾活血颗粒含药血清经miR-545-3P/Smad4调控BMSCs骨脂分化体外研究
In vitro study on the regulation of osteolipid differentiation of BMSCs by miR-545-3P/Smad4 in CKG containing serum
  
DOI:10.3969/j.issn.1006-7108.2026.11.007
中文关键词:  复方补肾活血颗粒  骨髓间充质干细胞  miR-545-3p  成骨分化  成脂分化
英文关键词:Compound Bushen Huoxue Granules  bone marrow mesenchymal stem cells  miR-545-3p  osteogenic differentiation  adipogenic differentiation
基金项目:安徽省自然科学基金项目(面上项目)(2308085MH294);安徽省重点研究与计划开发项目(202104j07020010);安徽省教育厅自然科学研究(重点项目)(2022AH050510)
作者单位
朱东东1,2# 竺应浩1,2# 吕浩1,2 衣海茹1,2 杨玉祥1,2 刘强1,2 王毅1,2 江渟2* 1.安徽中医药大学第一临床医学院,安徽 合肥 230031 2.安徽中医药大学,安徽 合肥 230031 
摘要点击次数: 57
全文下载次数: 0
中文摘要:
      目的 探讨复方补肾活血颗粒(compound kidney-invigorating granule,CKG)含药血清是否通过调控miR-545-3p/Smad4轴影响hBMSCs的成骨与成脂分化,明确miR-545-3p对hBMSCs分化命运的决定作用。方法 生物信息学分析验证miR-545-3p与smad4的结合位点,双荧光素酶报告验证miR-545-3p与smad4存在靶向关系;将hBMSCs分为对照组、阴性对照(NC inhibitor/mimic)组、miR-545-3p inhibitor/mimic转染组,以及CKG含药血清干预组(空白血清组,含药血清组、含药血清+oeNC组、含药血清+oemiR-545-3p组)。通过qPCR、Western blot检测miR-545-3p、Smad4及成骨(RUNX2、ALP、OCN)/成脂(PPARγ、FABP4)标志物的表达;采用ALP染色、茜素红染色和油红O染色分别评估成骨与成脂分化情况。结果 双荧光素酶报告证明miR-545-3p能够靶向smad4,抑制靶基因功能。过表达miR-545-3p可抑制Smad4的基因与蛋白表达(***P<0.001),阻遏其核转位;同时下调hBMSCs中ALP、RUNX2、OCN蛋白和基因表达(****P<0.0001),降低了钙节及阳性面积比例(***P<0.001),提高了PPARγ、FABP4的表达(****P<0.0001)和脂质积累。CKG含药血清抑制了miR-545-3p的表达(****P<0.0001),提高了smad4蛋白并促进入核表现,从而推动hBMSCs成骨分化,抑制其向脂肪细胞转变,且外源性过表达miR-545-3p时,部分逆转了复方补肾活血颗粒含药血清调节hBMSCs骨脂分化平衡的作用。结论 CKG含药血清通过抑制miR-545-3p表达,促进Smad4核转位,进而引导hBMSCs向成骨方向分化,抑制成脂分化,改善骨脂代谢平衡。
英文摘要:
      Objective This study investigated the intervention of CKG drug-containing serum on miR-545-3p-mediated osteolipid differentiation in hBMSCs via smad4, aiming to clarify the decisive role of miR-545-3p in determining hBMSC differentiation fate. Methods Bioinformatics analysis identified a binding site between miR-545-3p and smad4, which was confirmed by a dual-luciferase assay to be a targeting relationship. The hBMSCs were allocated to a control group, a negative control (NC inhibitor/mimic) group, a miR-545-3p inhibitor/mimic transfection group, and several CKG drug-containing serum intervention groups: a blank serum group, a drug-containing serum group, a drug-containing serum +oeNC group, and a drug-containing serum +oemiR-545-3p group. The expression levels of miR-545-3p, Smad4, and osteogenic (RUNX2, ALP, OCN) or adipogenic (PPARγ, FABP4) markers were quantified using qPCR and Western blot. Osteogenic and adipogenic differentiation were assessed via ALP staining, Alizarin Red S staining, and Oil Red O staining, respectively. Results The dual-luciferase assay confirmed that miR-545-3p targets smad4 and inhibits its function. Overexpression of miR-545-3p suppressed Smad4 gene and protein expression (***P<0.001) and impeded its nuclear translocation. This overexpression also reduced the protein and gene levels of ALP, RUNX2, and OCN (****P<0.0001), decreased the formation of calcium nodules and their positive area (***P<0.001), and increased the protein, gene, and lipid accumulation of PPARγ and FABP4 (****P<0.0001). CKG drug-containing serum inhibited miR-545-3p expression (****P<0.0001), enhanced smad4 protein levels and its nuclear entry, promoted osteogenic differentiation of hBMSCs, and suppressed adipocyte transformation. Exogenous overexpression of miR-545-3p partially reversed the effect of CKG drug-containing serum on regulating the osteolipid differentiation balance in hBMSCs. Conclusion CKG drug-containing serum promotes osteogenic differentiation and inhibits adipogenic differentiation in hBMSCs by suppressing miR-545-3p expression and facilitating the nuclear translocation of Smad4.
查看全文  查看/发表评论  下载PDF阅读器
关闭
function PdfOpen(url){ var win="toolbar=no,location=no,directories=no,status=yes,menubar=yes,scrollbars=yes,resizable=yes"; window.open(url,"",win); } function openWin(url,w,h){ var win="toolbar=no,location=no,directories=no,status=no,menubar=no,scrollbars=yes,resizable=no,width=" + w + ",height=" + h; controlWindow=window.open(url,"",win); } &et=1977fe6132cc4f05a32ee09085d7d193e78d3e3472f9e808a610d6023e393d91e94f07847589f67bc63ce6188b045cfb678971282cb892f18e7743bac6e66e2ae2e0104dad5b0f9ee0b1f9d3967c2ab14c4c109dffb11695ee194128e0a2da6331aef12968cebce2df9743e0c4bc254f50fba936eece2b559a8f01099fb59a25&pcid=3b2e4763797f121df1e5c0ba55cffa7b&cid=b38b646414cdcf7db2ea2d31acb25be6&jid=eee368637b75dadee990b657cb57bb74&yid=a76b0c4434fafe5bbe1e66b98fe1e513&aid=&vid=&iid=3854e790332c10656a5748ff60214cbb&sid=2f0019873b2ab872962cdddece7b8c91&eid=f8ec13c9c280bac64b4aca48a0a77270&fileno=202611007&flag=1&is_more=0"> var my_pcid="3b2e4763797f121df1e5c0ba55cffa7b"; var my_cid="b38b646414cdcf7db2ea2d31acb25be6"; var my_jid="eee368637b75dadee990b657cb57bb74"; var my_yid="a76b0c4434fafe5bbe1e66b98fe1e513"; var my_aid="";